首页|胃肠道疾病患者实施营养支持疗法的效果分析

胃肠道疾病患者实施营养支持疗法的效果分析

扫码查看
目的 分析胃肠道疾病患者实施营养支持疗法的效果。方法 150 例胃肠道疾病患者,随机分为对照组与治疗组,每组 75 例。对照组实施普通营养恢复计划,治疗组在对照组基础上实施营养支持疗法。比较两组患者营养指标[总蛋白(TP)、白蛋白(ALB)、血红蛋白(Hb)]、免疫指标[白细胞计数(WBC)、总淋巴细胞计数(TLC)]、内环境紊乱发生率及并发症发生率。结果 治疗 1、7、14 d,两组WBC比较,差异无统计学意义(P>0。05);治疗 1 d,两组TP、Hb、TLC、ALB比较,差异无统计学意义(P>0。05);治疗 7、14 d,治疗组TP、Hb、TLC、ALB分别为(59。70±5。42)g/L、(89。50±7。92)g/L、(146。60±4。75)×106/L、(29。60±5。85)g/L和(66。20±5。81)g/L、(101。30±10。11)g/L、(171。30±6。54)×106/L、(32。30±5。76)g/L,均高于对照组的(56。30±4。83)g/L、(82。30±8。43)g/L、(139。30±2。91)×106/L、(25。40±4。58)g/L和(59。10±4。31)g/L、(88。40±9。58)g/L、(158。80±3。76)×106/L、(29。30±5。13)g/L,差异具有统计学意义(P<0。05)。治疗组患者的内环境紊乱发生率为 6。67%,显著低于对照组的 18。67%,组间比较差异具有统计学意义(P<0。05)。治疗组并发症发生率 5。33%低于对照组的 26。67%,组间比较差异具有统计学意义(P<0。05)。结论 在临床实践中,对胃肠道疾病患者进行营养支持疗法可以有效提高其营养状况和免疫机能,提高临床疗效,减少并发症的发生,从而提高患者对治疗的满意度,临床价值高。
Effect analysis of nutritional support therapy in patients with gastrointestinal diseases
Objective To analyze the effect of nutritional support therapy in patients with gastrointestinal diseases.Methods 150 patients with gastrointestinal diseases were randomly divided into a control group and a treatment group,with 75 cases in each group.The control group received the normal nutrition recovery plan,and the treatment group received nutritional support therapy based on the control group.The nutritional indexes[total protein(TP),albumin(ALB),hemoglobin(Hb)],immune indexes[white blood cell count(WBC),total lymphocyte count(TLC)],incidence of internal environment disturbance,and complication rate were compared between the two groups.Results After 1,7 and 14 d of treatment,there was no significant difference in WBC between the two groups(P>0.05).After 1 d of treatment,there was no significant difference in TP,Hb,TLC and ALB between the two groups(P>0.05).After 7 and 14 d of treatment,in the treatment group,TP,Hb,TLC and ALB were(59.70±5.42)g/L,(89.50±7.92)g/L,(146.60±4.75)×106/L,(29.60±5.85)g/L and(66.20±5.81)g/L,(101.30±10.11)g/L,(171.30±6.54)×106/L,(32.30±5.76)g/L,which were higher than(56.30±4.83)g/L,(82.30±8.43)g/L,(139.30±2.91)×106/L,(25.40±4.58)g/L and(59.10±4.31)g/L,(88.40±9.58)g/L,(158.80±3.76)×106/L,(29.30±5.13)g/L in the control group.The difference was statistically significant(P<0.05).The incidence of internal environment disturbance in the treatment group was 6.67%,which was significantly lower than 18.67%in the control group,and the difference between groups was statistically significant(P<0.05).The complication rate in the treatment group was 5.33%,which was lower than 26.67%in the control group,and the difference between groups was statistically significant(P<0.05).Conclusion In clinical practice,nutritional support therapy is of high clinical value for patients with gastrointestinal diseases,which can effectively improve their nutritional status and immune function,improve clinical efficacy,reduce the occurrence of complications,and thus improve the treatment satisfaction of patients.

Gastrointestinal diseasesNutritional support therapyRehabilitation

黄冬梅、黄小玲

展开 >

362000 福建医科大学附属第二医院

胃肠道疾病 营养支持疗法 康复

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(2)
  • 27